Relaxing environment reduces anxiety before office intradetrusor chemodenervation in women with OAB
A single-center randomized trial evaluated whether a relaxing environment could reduce anxiety before office intradetrusor chemodenervation with onabotulinumtoxinA for overactive bladder. The study enrolled 80 women, comparing a relaxing environment (lavender aromatherapy, calming music, and dim lighting) to a typical office environment. The primary outcome was patient anxiety measured by a Visual Analog Scale (VAS).
Patients in the relaxing environment group reported a clinically significant reduction in anxiety, with a mean change of -13.8 ± 18.1 on the VAS compared to -4.7 ± 14.7 in the control group (P = 0.015). For the secondary outcome of pain, the relaxing environment group had a mean VAS score of 21.9 versus 28.9 in the control group, but this difference was not statistically significant (P = 0.261). Patient satisfaction scores were high in both groups (91.4 vs. 89.3) and not significantly different. The intervention did not affect staff energy levels.
Safety and tolerability data were not reported. Key limitations include the single-center design and lack of significant effects on pain or satisfaction. The findings suggest this easily implemented, noninvasive technique may help reduce pre-procedure anxiety for women undergoing this specific office-based procedure, but its generalizability to other settings or populations is unclear.